Healius Ltd (hls) Logo

Healius Ltd (HLS)

___:___ · AUD

HLS Chart

HLS's Principal Activity is the provision of pathology, imaging and day hospitals and also facilities & support services to general practitioners, radiologists and other healthcare professionals.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2021 YTD
1 Year
vs Sector (1yr) +42.28%
vs ASX 200 (1yr) +29.47%


Market Capitalisation
ASX Rank 142 of 2,297
Sector Rank 10 of 177

Key Information

Shares Issued
Sector Healthcare
Similar Companies SNZ / IMU / NAN
EPS -$0.119
DPS $0.091
NTA per share -$0.32

Broker Consensus

Breakdown 7 Buy · 6 Hold · 1 Sell
Recommendation Buy
Last Updated 01/07/21


Date Heading Pages File Size Time

Company Overview

Healius Limited (HLS) is a healthcare company which provides facilities and support services to independent general practitioners, radiologists and a range of other healthcare professionals. Healius has three main businesses - Pathology, Imaging and Day Hospitals.

Incorporation Details

Incorporated Incorporated on 17 May 1994 in Victoria, Australia.

Corporate Details

Head Office St Leonards NSW 2065
Website www.healius.com.au
Registry Computershare
Auditor Ernst & Young
Date Listed 3 Jul 1998

Upcoming Calendar (Forecasted)

Date Event
20/08/2021 Report (Prelim)
08/09/2021 Report (Annual)
23/02/2022 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
25/03/2021 $0.065 100% $0.0929 Interim 15/04/2021
26/03/2020 $0.026 100% $0.0371 Interim 15/10/2020
29/08/2019 $0.034 100% $0.0486 Final 27/09/2019
15/03/2019 $0.038 100% $0.0543 Interim 26/03/2019
27/08/2018 $0.055 100% $0.0786 Final 17/09/2018

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.091
Gross DPS(TTM) $0.13
Dividend yield
Gross yield
Payout Ratio 25%
DRP Features no discount

Directors & Management

Directors & Management

Name Title Since Bio
Ms Kathryn (Kate) Mary McKenzie Non-Executive Director Feb 2021 Director Bio icon

Ms Kathryn (Kate) Mary McKenzie

Non-Executive Director

Ms McKenzie is an experienced Chief Executive Officer and Non-executive Director with experience in change management and turnarounds ranging across both the private and public sector, with knowledge in the telecommunications sector. Kate commenced her career in the public sector, working in various roles including as Deputy DirectorGeneral within the NSW Government. Kate then took on the role of Chief Executive Officer of the Workcover Authority in 2000, a reform of the scheme to return it to financial health. After almost three years in this role, Kate moved to the Department of Industrial Relations and then the Department of Commerce. Kate was approached to join Telstra in 2004 as the Group Managing Director Regulatory, Public Policy and Communications. In her 12 years at Telstra, Kate held a range of Senior Executive roles in strategy, marketing, products and wholesale. Her last Executive role at Telstra was as Chief Operating Officer, responsible for networks, IT, field services, property and NBN relations and delivery. In 2017 Kate was appointed Chief Executive Officer of Chorus, a New Zealand top 50 listed telecommunications company. Kate also initiated cultural change and infrastructure transformation, implementing a digitisation and process efficiency program. Kate has knowledge in the field of innovation and technology, creating new product lines at Telstra - cloud, bundles, shared data plans and software as a service and delivering a framework based around incubation, collaboration, human capital and new methods and technologies. Through this framework, Kate co-founded muru-D, an incubator which has produced 44 graduating companies, with 41 still in operation; Gurrowa, a co-creation lab, and partnerships with universities, such as investment in Quantum computing with the University of New South Wales. Kate currently serves on the Boards of AMP Limited, nbn co Limited and Stockland Corporation Limited, and was previously on the Boards of Allianz, Foxtel, Sydney Water, Reach, CSL (a Hong Kong mobile business that Telstra had a stake in) and Workcover.

Ms Jennifer (Jenny) Mitchell Macdonald Non-Executive Director Nov 2020 Director Bio icon

Ms Jennifer (Jenny) Mitchell Macdonald

Non-Executive Director

Ms Macdonald has a background in financial and general management roles across a range of industry sectors including fast moving consumer goods, resources, travel and digital media. Jenny commenced her career with KPMG, working in the Sydney, London and Melbourne offices in a number of practice areas over more than ten years with that firm. In Melbourne, as an Audit Manager, she was responsible for the audit and advisory function of several clients. After gaining experience in the resources sector, Jenny's more recent executive roles were in the travel and tourism industries and digital media at Flight Centre, Helloworld and REA Group. From 2014-2016 Jenny was the Chief Financial Officer and then Interim Chief Executive Officer of Helloworld, an ASX-listed multi-channel travel company. During her time at Helloworld, Jenny transformed that company's New Zealand operation and also led the acquisition of the AOT Group. Since 2017 Jenny has worked as a professional Non-executive Director. She currently serves on the boards of listed entities Bapcor Limited (ASX:BAP) (2018-present), Redbubble (ASX:RBL) (2018-present); and Australian Pharmaceutical Industries (ASX:API) (2017-present), as well as on the board of (unlisted) PropertyGuru Group (2019-present).

Ms Alison Stephenson Company Secretary Aug 2019
Ms Sally Evans Non-Executive Director Aug 2018 Director Bio icon

Ms Sally Evans

Non-Executive Director

Ms Evans has over 30 years experience in government enterprise sectors and has worked in Australia, New Zealand, the United Kingdom and Hong Kong with responsibilities across the Asia Pacific region. She has served as a Non-executive Director of Gateway Lifestyle Operations Limited. She is a Member of the the Risk Management Committee and Chair of the People & Governance Committee.

Dr Malcolm Parmenter Chief Executive Officer,Managing Director Sep 2017 Director Bio icon

Dr Malcolm Parmenter

Chief Executive Officer,Managing Director

Dr Parmenter has knowledge and experience in the operation of frontline care, with over nine years tenure as CEO of Independent Practitioner Network Limited (IPN), both as a listed company and under the ownership of Sonic Healthcare Limited, and subsequently two years as CEO of Sonic Clinical Services. He has understanding of healthcare delivery, both in Australia and abroad, and has spent more than 20 years as a General Practitioner.

Mr Gordon Richard Davis Non-Executive Director Aug 2015 Director Bio icon

Mr Gordon Richard Davis

Non-Executive Director

Mr Davis was Managing Director of AWB Limited between 2006 and 2010. He has also served in a senior capacity on industry associations. He is Chair of the Risk Management Committee.

Mr Charles Tilley Company Secretary Feb 2015
Mr Robert Hubbard Non-Executive Director,Non-Executive Chairman Dec 2014 Director Bio icon

Mr Robert Hubbard

Non-Executive Director,Non-Executive Chairman

Mr Hubbard previously held partnership positions in the accounting, corporate finance, assurance and audit divisions of PricewaterhouseCoopers and acted as external auditor for some of Australia's ASX-listed companies. He is a Member of the People & Governance Committee and was a member of the Risk Management Committee.

Dr Paul Francis Jones Non-Executive Director Nov 2010 Director Bio icon

Dr Paul Francis Jones

Non-Executive Director

Dr Jones has over 35 years experience in a range of general medical practice. He originally trained at the Repatriation and General Hospital, Concord NSW and subsequently at Calvary Public Hospital, Bruce ACT. He has been a Director and Federal Councillor of the Australian Medical Association (AMA), a past President of AMA ACT. He was formerly a general practitioner adviser to Calvary Public Hospital and held roles as GPVMO and Director, Medical Education Program. He is a former Chair of ACT GP Workforce Group and was a Member of the ACT Health Minister's GP Task Force in 2009. He is member of the People & Governance Committee and the Risk Management Committee.

Ben Korst Chief Executive Day Hospitals N/A
Dean Lewsam Chief Executive Imaging N/A
Scott Beattie Chief Executive Medical Centres N/A
John McKechnie Chief Executive Pathology N/A
Maxine Jaquet Chief Financial Officer N/A
Janet Payne Group Executive Corporate Affairs N/A
Mark Neeham Group Executive Government & External Affairs N/A
Peter Wilson Group Executive People & Shared Services N/A

Director Transactions

HLS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
26/02/21 Kathryn (Kate) McKenzie Buy +2,500 $4.07 $10,175 On-market trade
25/02/21 Robert Hubbard Buy +7,172 $3.483 $24,977 Conversion of securities
25/02/21 Robert Hubbard Exercise 7,172 $3.483 $24,977 Conversion of securities
25/02/21 Sally Evans Buy +3,586 $3.485 $12,498 Conversion of securities
25/02/21 Sally Evans Exercise 3,586 $3.485 $12,498 Conversion of securities
10/12/20 Paul Jones Buy +2,869 $3.485 $9,999 Conversion of securities
10/12/20 Paul Jones Exercise 2,869 $3.485 $9,999 Conversion of securities
10/12/20 Sally Evans Issued 10,759 $3.485 $37,500 Directors' share plan
10/12/20 Robert Hubbard Issued 21,518 $3.485 $75,000 Directors' share plan
10/12/20 Paul Jones Issued 8,607 $3.486 $30,000 Directors' share plan
10/11/20 Jennifer (Jenny) Macdonald Buy +15,000 $3.51 $52,650 On-market trade
14/08/20 Malcolm Parmenter Expiry 475,180 $3.18 $1,511,072 As advised by the company
01/07/20 Malcolm Parmenter Exercise 26,537 $3.10 $82,264 Conversion of securities
01/07/20 Malcolm Parmenter Issued 26,537 $3.10 $82,264 Conversion of securities
03/03/20 Malcolm Parmenter Issued 11,081,391 $3.01 $33,354,987 Issue of options
25/11/19 Errol Katz Transfer 25,000 $3.04 $76,000 Off-market transfer
25/11/19 Errol Katz Transfer 25,000 $3.04 $76,000 Off-market transfer
13/09/19 Sally Evans Buy +15,000 $3.26 $48,900 On-market trade
19/08/19 Robert Hubbard Buy +25,000 $3.086 $77,150 On-market trade
29/01/19 Malcolm Parmenter Issued 804,980 $2.90 $2,334,442 Issue of securities
21/12/18 Errol Katz Buy +13,080 $2.25 $29,430 On-market trade
27/11/18 Arlene Tansey Buy +4,000 $2.52 $10,080 On-market trade
14/09/18 Gordon Davis Issued 5,759 $2.50 $14,398 Rights issue
14/09/18 Errol Katz Issued 1,920 $2.50 $4,800 Rights issue
14/09/18 Paul Jones Issued 6,536 $2.50 $16,340 Rights issue
14/09/18 Arlene Tansey Issued 1,920 $2.50 $4,800 Rights issue
14/09/18 Malcolm Parmenter Issued 9,597 $2.50 $23,993 Rights issue
31/08/18 Robert Hubbard Buy +15,000 $2.79 $41,850 On-market trade
31/08/18 Gordon Davis Buy +20,000 $2.717 $54,335 On-market trade

Director Interests

The current holdings of HLS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Kathryn (Kate) McKenzie 26/02/2021 0 2,500 N/A N/A
Sally Evans 25/02/2021 3,586 15,000 N/A N/A
Robert Hubbard 25/02/2021 7,172 76,951 N/A N/A
Paul Jones 10/12/2020 2,869 40,588 0 N/A
Jennifer (Jenny) Macdonald 10/11/2020 15,000 N/A N/A N/A
Malcolm Parmenter 01/07/2020 51,998 N/A 11,081,391 N/A
Gordon Davis 30/06/2020 N/A 55,759 N/A N/A

Shareholder Info

Top 20 Shareholders About the Data

Data supplied by Morningstar and accurate on Aug 31, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 174,206,628 27.96%
Jangho Health Care Australia Pty Ltd and its related bodies corporate 98,946,666 15.88%
J P Morgan Nominees Australia Pty Limited 94,180,700 15.12%
Citicorp Nominees Pty Limited 65,727,145 10.55%
National Nominees Pty Ltd 53,339,969 8.56%
Argo Investments Limited 13,820,664 2.22%
BNP Paribas Noms Pty Ltd <DRP> 12,248,730 1.97%
BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C> 9,986,725 1.60%
HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 7,347,317 1.18%
UBS Nominees Pty Ltd 6,174,498 0.99%
HSBC Custody Nominees (Australia) Limited GSCO ECA 2,864,847 0.46%
Citicorp Nominees Pty Ltd <Colonial First State Inv A/C> 2,468,936 0.40%
RinRim Pty Ltd 2,392,047 0.38%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> 1,175,335 0.19%
Nulis Nominees (Australia) Limited <Navigator Mast Plan Sett A/C> 900,643 0.14%
Navigator Australia Ltd <MLC Investments Sett A/C> 856,037 0.14%
Joromada Pty Ltd 800,000 0.13%
Hsbc Custody Nominees (Australia) Limited I 719,614 0.12%
Netwealth Investments Limited <WRAP Services A/C> 645,615 0.10%
Mr Gregory Anthony Thomas Bateman 636,213 0.10%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 3,843 5,934 2,144 1,470 64 13,455

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Jangho Health Care Australia Pty Ltd 31/08/2020 98,946,666 15.88
Dimensional Entities 31/08/2020 34,956,718 5.61
Yarra Funds Management Limited 03/12/2020 43,133,257 6.92
Vinva Investment Management 22/07/2021 31,595,448 5.07

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
22-07-21 Vinva Investment Management 31,595,448 -- 5.07
12-04-21 Yarra Capital Management Limited 39,367,201 -- 6.32
04-03-21 Vanguard Group 31,170,341 -- 5.00
03-12-20 Yarra Funds Management Limited 11,767,813 5.03 6.92
02-12-20 Jarden Australia Pty Limited 93,128,981 -- 14.90
28-09-20 Yarra Funds Management Limited 31,365,444 -- 5.03

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
09-06-21 Yarra Capital Management Limited 32,925,092 5.28 --
19-05-21 Yarra Capital Management Limited 6,442,109 6.32 5.28
06-04-21 Vanguard Group 31,170,341 5.00 --
07-12-20 Jarden Australia Pty Limited 93,128,981 14.90 --
07-12-20 Golden Acumen Holdings Limited 99,096,666 15.93 --
29-10-20 EAB Holdings Pte Ltd 98,946,666 15.88 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $3.05 30 June
2019 $3.02 28 June
2016 $0.005 28 June
2015 $0.003 30 June
2014 $0.006 30 June
Page Icon
HLS Historical Price Data (CSV)
Up to 20 years of EOD share price history
Lock Icon
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.